The findings showing the importance of the OSCN− production via the pendrin/DUOX/peroxidase pathway in asthma indicate that all of the machineries of the OSCN− production system can be viewed as potential novel therapeutic targets for asthma. This evidence concerns the gene DUOX1 and asthma.